Highlights from our PHUTURE Event, Italy 2023 - Stevanato Group
Home - Managing Complexity, Delivering Value - Stevanato Group > News & Events - Stevanato Group > News - Stevanato Group > Highlights from our PHUTURE Event, Italy 2023 - Stevanato Group
page-wrapper

APR 20 |

 2023

Highlights from our PHUTURE Event, Italy 2023

APR 20 |

 2023

Highlights from our PHUTURE Event, Italy 2023

Throwback to our Phuture Event!  

On April 20th, we inaugurated our new facility in Piombino Dese (Italy), dedicated to Drug Containment Solutions and Analytical Services.

Among some of the hottest topics in the pharma scenario, our guests have learned all about our Alba® platform, a best-in-class solution to address the development of sensitive biologics, while becoming acquainted with our state-of-the-art Technology Excellence Center showcasing our holistic approach to R&D and product development!  

It has been a great opportunity to demonstrate to our customers how we can support them from the early stage of product development all the way to commercialization, offering a unique approach as a one-stop-shop provider.  

It has been an inspiring time together, working side-by-side to build the pharma of the future


Check out this enthralling snippet! 

 

CONFERENCE SESSIONS – WHAT OUR GUEST SPEAKERS SAY ABOUT US!  

We are grateful to Sheldon Moberg, Sr. VP of Drug Delivery at Bexson Biomedical, and Guido Dietrich, Vaccine Manufacturing and Quality Expert Coalition for Epidemic Preparedness Innovations (CEPI) for sharing their experience with Stevanato Group during our Phuture event.  

Sheldon highlighted our team's technical capabilities and the forward-thinking approach he experienced with us during our collaboration on a new wearable pump. At Stevanato Group, we believe in starting with first principles, modeling before testing empirically, and building the appropriate architecture to solve problems of the future.  

Guido praised Stevanato Group for their critical role in delivering numerous doses of COVID vaccines worldwide. Most of these doses were filled into multi-dose glass vials from Stevanato Group, and the company's EZ-fill®️ ready-to-use vials and syringes are seen as important innovations to help reduce the time it takes to deliver vaccine doses during future pandemics. 

Thank you both for your precious contributions.

WATCH SHELDON’S INTERVIEW  

WATCH GUIDO’S INTERVIEW  

CURIOUS TO KNOW WHAT OUR CUSTOMERS SAY ABOUT US? 

Don’t miss this engaging video!

Other News